8-K: INVO Fertility Implements 1-for-3 Reverse Stock Split to Meet Nasdaq Listing Requirements

INVO Fertility, Inc. has announced a 1-for-3 reverse stock split, effective July 21, 2025, primarily aimed at regaining compliance with Nasdaq's minimum bid price requirement.

Summary

• INVO Fertility, Inc. filed a Certificate of Change with the Secretary of State of Nevada to effectuate a 1-for-3 reverse stock split of its common stock.
• The reverse stock split became effective at 12:01 a.m., Eastern Time, on Monday, July 21, 2025.
• The company's Common Stock began trading on a split-adjusted basis when The Nasdaq Stock Market opened on July 21, 2025.
• Every 3 shares of issued and outstanding Common Stock were automatically reclassified and combined into one share of Common Stock.
• The par value per share of $0.0001 remained unchanged.
• A proportionate adjustment was made to the company's authorized shares of Common Stock, resulting in 1,388,888 authorized shares post-split.
• Immediately after the reverse stock split, the company has approximately 928,272 shares of common stock issued and outstanding.
• Proportionate adjustments were made to the per share exercise price and the number of shares issuable upon the exercise of all outstanding stock options and warrants, as well as shares reserved for equity incentive compensation plans.
• No fractional shares were issued; stockholders entitled to fractional shares had their holdings rounded up to the next whole share.
• The Common Stock continues to trade on The Nasdaq Capital Market under the existing symbol IVF, but has been assigned a new CUSIP number (44984F708).

Sentiment

Score: 3

Explanation: While the action addresses a critical compliance issue (Nasdaq listing), the underlying reason for the reverse split (low share price) is generally a negative indicator of the company's market performance and investor confidence. The lack of assurance regarding regaining compliance adds to the uncertainty.

Positives

• The reverse stock split is a proactive measure to address Nasdaq's minimum bid price requirement, potentially preventing delisting and maintaining the company's presence on a major exchange.
• Stockholders who would have received fractional shares had their holdings rounded up to the next whole share, which is a minor benefit.

Negatives

• The necessity of a reverse stock split often indicates a sustained period of low share price, which can be perceived negatively by investors and may signal underlying financial or operational challenges.
• There is no assurance that the reverse stock split will enable the company to regain compliance with the Nasdaq minimum bid price requirement.

Risks

• No assurance can be given that the reverse stock split will enable the company to regain compliance with the Nasdaq minimum bid price requirement of $1.00 per share for continued listing.
• Forward-looking statements involve risks, uncertainties, and contingencies, many of which are beyond the company's control, which may cause actual results to differ materially from anticipated results.

Future Outlook

The reverse stock split is primarily intended to bring the company into compliance with Nasdaq's $1.00 per share minimum bid price requirement for continued listing. However, no assurance can be given that this action will enable the company to regain compliance.

Management Comments

• INVO Fertility, Inc. announced that it will effect a 1-for-3 reverse split of its issued and outstanding and authorized common stock effective as of 12:01 a.m. Eastern Time on July 21, 2025.
• The reverse stock split is primarily intended to bring the Company into compliance with Nasdaq's $1.00 per share minimum bid price requirement for continued listing.

Industry Context

INVO Fertility operates in the healthcare services fertility market, focusing on assisted reproductive technology (ART) care, including INVO Centers and IVF clinics. The reverse stock split is a corporate finance action taken to maintain stock exchange listing, which is crucial for capital market access and investor visibility within the competitive healthcare industry.

Comparison to Industry Standards

• Reverse stock splits are a common corporate action undertaken by companies across various industries, including healthcare, when their stock price falls below exchange minimum bid price requirements. This action is a standard mechanism to address such compliance issues.
• The specific ratio of 1-for-3 is within the typical range for reverse splits aimed at increasing share price to meet listing standards.

Corporate Governance

Stakeholder Impact

• Shareholders: The number of shares held will decrease by a 1-for-3 ratio, but the total value of their holdings should theoretically remain the same immediately after the split. Fractional shares are rounded up, which is a minor benefit. The primary impact is the attempt to maintain Nasdaq listing, which preserves liquidity and visibility for their investment.
• Investors: The need for a reverse split due to a low stock price may raise concerns about the company's financial health or market performance, potentially affecting investor sentiment and future investment decisions. However, maintaining the Nasdaq listing is crucial for institutional investment and broader market access.

Next Steps

• The company's Common Stock will continue to trade on The Nasdaq Capital Market under the existing symbol IVF with the new CUSIP number (44984F708).
• The company will need to monitor its stock price to ensure it regains and maintains compliance with Nasdaq's minimum bid price requirement.

Key Dates

Recommendation

Keywords

INVO Fertility, reverse stock split, Nasdaq compliance, IVF, common stock, corporate action, fertility market, INVOcell, healthcare, SEC filing